ASSET | DATE | % RETURN |
---|---|---|
Inspire Veterinary Partners, Inc Class A Common Stock (IVP) | 7/1/2024 - 7/10/2024 | 374.36% |
Zapp Electric Vehicles Group Limited Ordinary Shares (ZAPP) | 7/1/2024 - 7/10/2024 | 362.87% |
Crown LNG Holdings Limited Warrants (CGBSW) | 7/1/2024 - 7/10/2024 | 267.47% |
Soligenix (SNGX) | 7/1/2024 - 7/10/2024 | 199.61% |
Longeveron LLC (LGVN) | 7/1/2024 - 7/10/2024 | 182.61% |
Kazia Therapeutics Ltd ADR (KZIA) | 7/1/2024 - 7/10/2024 | 179.7% |
VivoPower International (VVPR) | 7/1/2024 - 7/10/2024 | 125.93% |
SUNation Energy (SUNE) | 7/1/2024 - 7/10/2024 | 120.63% |
Connexa Sports Technologies (YYAI) | 7/1/2024 - 7/10/2024 | 116.87% |
Antelope Enterprise (AEHL) | 7/1/2024 - 7/10/2024 | 108.4% |
Annovis Bio (ANVS) | 7/1/2024 - 7/10/2024 | 101.67% |
Koss (KOSS) | 7/1/2024 - 7/10/2024 | 87.7% |
Nisun International Enterprise Development (NISN) | 7/1/2024 - 7/10/2024 | 87.29% |
Naas Technology Inc ADR (NAAS) | 7/1/2024 - 7/10/2024 | 86.45% |
Cyclerion Therapeutics (CYCN) | 7/1/2024 - 7/10/2024 | 79.72% |
Cingulate (CING) | 7/1/2024 - 7/10/2024 | 78.02% |
Baijiayun (RTC) | 7/1/2024 - 7/10/2024 | 73.02% |
ZyVersa Therapeutics (ZVSA) | 7/1/2024 - 7/10/2024 | 69.32% |
NLS Pharmaceutics (NLSPW) | 7/1/2024 - 7/10/2024 | 66.67% |
NextTrip (NTRP) | 7/1/2024 - 7/10/2024 | 65.59% |
Nature Wood Group Limited American Depositary Shares (NWGL) | 7/1/2024 - 7/10/2024 | 64.71% |
Vicarious Surgical (RBOT) | 7/1/2024 - 7/10/2024 | 59.21% |
Scienture (SCNX) | 7/1/2024 - 7/10/2024 | 57.7% |
Ampco-Pittsburgh (AP) | 7/1/2024 - 7/10/2024 | 55.7% |
ProMIS Neurosciences (PMN) | 7/1/2024 - 7/10/2024 | 54.42% |